Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 54 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Bekiari, Eleni [Clear All Filters]
(2024).
Burden and Coping Strategies of Hypoglycemia in People with Diabetes..
Curr Diabetes Rev.
(2023). Comparative efficacy of glucose-lowering drugs on liver steatosis as assessed by means of magnetic resonance imaging in patients with type 2 diabetes mellitus: systematic review and network meta-analysis..
Hormones (Athens). 22(4), 655-664.
(2023). Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis..
Diabetes Obes Metab. 25(10), 3020-3029.
(2023). Management of type 2 diabetes in the new era..
Hormones (Athens). 22(4), 677-684.
(2023). Racial, ethnic and sex disparities among participants in cardiovascular outcomes trials in type 2 diabetes: A systematic review and descriptive analysis..
Diabetes Obes Metab. 25(2), 618-622.
(2023). A Simple Guide to Systematic Reviews and Meta-Analyses..
Int J Low Extrem Wounds. 15347346231169842.
(2023). Socioeconomic aspects of incretin-based therapy..
Diabetologia. 66(10), 1859-1868.
(2023). Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis..
Diabetologia. 65(8), 1251-1261.
(2022). Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysis..
Diabetes Obes Metab. 24(1), 106-114.
(2022). Add-on interventions for the prevention of recurrent Clostridioides Difficile infection: A systematic review and network meta-analysis..
Anaerobe. 71, 102441.
(2021). Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes..
Ann Intern Med. 174(1), 141.
(2021). Comparative efficacy and safety of glucose-lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta-analysis..
Diabetes Obes Metab. 23(3), 822-831.
(2021). Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta-analysis..
Diabetes Obes Metab. 23(9), 2116-2124.
(2021). GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis..
Diabetes Res Clin Pract. 174, 108737.
(2021). GLP-1 receptor agonists for cardiovascular outcomes with and without metformin. A systematic review and meta-analysis of cardiovascular outcomes trials..
Diabetes Res Clin Pract. 177, 108921.
(2021). KDIGO made 12 recommendations for managing diabetes with CKD..
Ann Intern Med. 174(3), JC26.
(2021). Ultra-rapid-acting insulins for adults with diabetes: A systematic review and meta-analysis..
Diabetes Obes Metab. 23(10), 2395-2401.
(2021). Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis..
Ann Intern Med. 173(4), 278-286.
(2020). Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta-analysis..
Diabetes Obes Metab. 22(10), 1857-1868.
(2020). In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors..
Ann Intern Med. 173(12), JC70.
(2020). Some glucose-lowering drugs reduce risk for major adverse cardiac events..
Ann Intern Med. 173(2), JC9.
(2020). Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-Risk Varices in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis..
Clin Gastroenterol Hepatol. 17(9), 1744-1755.e11.
(2019).
(2018).
(2018).